SCHEMBL7092691

SCHEMBL7092691

CCN(CCCCN(CCCCN(CCCCN(CC)S(=O)(=O)c1ccc(C)cc1)S(=O)(=O)c1ccc(C)cc1)S(=O)(=O)c1ccc(C)cc1)S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 4/20 0.57
HTT P42858 4/20 0.56
LMNA P02545 3/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
RAB9A P51151 2/20 0.56
NPC1 O15118 1/20 0.56
SERPINE1 P05121 1/20 0.54
ALDH1A1 P00352 2/20 0.54
GLA P06280 1/20 0.53
HTR7 P34969 1/20 0.50
CA12 O43570 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
SLC22A8 Q8TCC7 1/20 0.50
ABCC2 Q92887 1/20 0.50
SLC22A12 Q96S37 1/20 0.50
UGT1A7 Q9HAW7 1/20 0.50
SLC22A11 Q9NSA0 1/20 0.50
KDM4E B2RXH2 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7206014 0.98 CNR2 (0.56) CNR2HTTLMNASMN1; SMN2RAB9A
SCHEMBL7096609 0.98 CNR2 (0.59) CNR2HTTLMNASMN1; SMN2RAB9A
SCHEMBL7095958 0.98 CNR2 (0.56) CNR2HTTLMNASMN1; SMN2RAB9A
SCHEMBL7097469 0.98 CNR2 (0.59) CNR2HTTLMNASMN1; SMN2RAB9A
SCHEMBL7092599 0.98 CNR2 (0.59) CNR2HTTLMNASMN1; SMN2RAB9A
SCHEMBL7092601 0.98 CNR2 (0.59) CNR2HTTLMNASMN1; SMN2RAB9A
SCHEMBL7201208 0.98 CNR2 (0.56) CNR2HTTLMNASMN1; SMN2RAB9A
SCHEMBL7091255 0.98 CNR2 (0.59) CNR2HTTLMNASMN1; SMN2RAB9A
SCHEMBL6895598 0.98 CNR2 (0.56) CNR2HTTLMNASMN1; SMN2RAB9A
SCHEMBL7091892 0.98 CNR2 (0.59) CNR2HTTLMNASMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627399-B1 Using compound of given formula as accelerator RIKEN (JP) 2003-09-30 US disclosed
US-6605645-B2 Such as 1,15-di(cyclopropylmethylamino)-8-benzyl-4,8,12-triazapentadecane; carcinostatic action RIKEN (JP) 2003-08-12 US disclosed
US-20030073202-A1 RNA polymerase transcription promoter and nucleic acid sequencing method IWATA MASAAKI (JP) 2003-04-17 US disclosed
US-20020067472-A1 Linear polyamine compounds and polyamine anticancer agents IWATA MASAAKI (JP) 2002-06-06 US disclosed
US-6319956-B1 N1, N4-BIS(CYCLOPROPYLMETHYLAMINO)TRIALKYLENETETRAMINES THAT MAY BE TOLUENESULFONATED. RIKEN (JP) 2001-11-20 US disclosed
EP-1061130-A1 RNA POLYMERASE TRANSCRIPTION PROMOTERS AND METHOD FOR DETERMINING BASE SEQUENCE Riken (JP) 2000-12-20 EP disclosed